US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.64

+0.09002.54%

Post-market: 3.57-0.0700-1.92%19:01 EDT

Volume:296.67K

Turnover:1.08M

Market Cap:200.95M

PE:-3.22

High:3.69

Open:3.57

Low:3.56

Close:3.55

Loading ...

Overview Company News Filings

Voyager Therapeutics Inc - Estimates Cash Runway Into Mid-2027

THOMSON REUTERS

Voyager Therapeutics Inc - to Assess Alternate Payloads for Sod1 ALS Program

THOMSON REUTERS

Voyager Therapeutics Inc - Will Not File Ind or Cta for Vy9323 in Mid-2025

THOMSON REUTERS

Voyager Therapeutics Inc - Cash Runway Expected to Extend Into Mid-2027

THOMSON REUTERS

Voyager Therapeutics Inc - to Assess Alternate Payloads for Sod1 ALS Gene Therapy

THOMSON REUTERS

Voyager Therapeutics Inc - Expects Ind Filings in 2025 for Gba1 and Fa, 2026 for Vy1706

THOMSON REUTERS

Voyager Therapeutics Inc - No Longer Anticipates Ind Filing for Vy9323 in Mid-2025

THOMSON REUTERS

Voyager Provides Update on Sod1 ALS Gene Therapy Program

THOMSON REUTERS

Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference

What Makes Voyager Therapeutics (VYGR) a New Buy Stock

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Is it a Good Idea to Invest in Beam Therapeutics Stock Now?

NTLA Begins Dosing in Pivotal Study on Hereditary Angioedema Candidate

REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA

J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use

Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise

Oppenheimer Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VYGR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VYGR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYGR\",,,,,undefined,":{"symbol":"VYGR","market":"US","secType":"STK","nameCN":"Voyager Therapeutics","latestPrice":3.64,"timestamp":1746216000000,"preClose":3.55,"halted":0,"volume":296673,"hourTrading":{"tag":"盘后","latestPrice":3.57,"preClose":3.64,"latestTime":"19:01 EDT","volume":4023,"amount":14588.27,"timestamp":1746226912569},"delay":0,"floatShares":45086463,"shares":55206885,"eps":-1.13,"marketStatus":"Market Closed","change":0.09,"latestTime":"05-02 16:00:00 EDT","open":3.57,"high":3.69,"low":3.56,"amount":1077972.4707375,"amplitude":0.03662,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.13,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1447218000000,"exchange":"NASDAQ","adjPreClose":3.55,"preHourTrading":{"tag":"盘前","latestPrice":3.67,"preClose":3.55,"latestTime":"08:24 EDT","volume":1,"amount":3.67,"timestamp":1746188674089},"postHourTrading":{"tag":"盘后","latestPrice":3.57,"preClose":3.64,"latestTime":"19:01 EDT","volume":4023,"amount":14588.27,"timestamp":1746226912569},"volumeRatio":1.4883273462169713,"impliedVol":0.8999,"impliedVolPercentile":0.48},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYGR\",,,,,undefined,":{"symbol":"VYGR","floatShares":45086463,"roa":"-13.99%","roe":"-24.25%","lyrEps":-1.127185,"volumeRatio":1.4883273462169713,"shares":55206885,"dividePrice":0,"high":3.69,"amplitude":0.03662,"preClose":3.55,"low":3.56,"week52Low":2.75,"pbRate":"0.67","psRate":"2.51","week52High":9.55,"institutionHeld":0,"latestPrice":3.64,"eps":-1.13,"divideRate":0,"volume":296673,"delay":0,"ttmEps":-1.13,"open":3.57,"prevYearClose":5.67,"prevWeekClose":3.47,"prevMonthClose":3.56,"prevQuarterClose":3.38,"fiveDayClose":3.47,"twentyDayClose":3.11,"sixtyDayClose":5.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VYGR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510800688","title":"Voyager Therapeutics Inc - Estimates Cash Runway Into Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800688?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:08","pubTimestamp":1739275699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P20QH:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VYGR"],"gpt_icon":0},{"id":"2510529800","title":"Voyager Therapeutics Inc - to Assess Alternate Payloads for Sod1 ALS Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2510529800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510529800?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:08","pubTimestamp":1739275699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P20QH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2510180052","title":"Voyager Therapeutics Inc - Will Not File Ind or Cta for Vy9323 in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510180052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510180052?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:08","pubTimestamp":1739275699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nFWN3P20QH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2510890800","title":"Voyager Therapeutics Inc - Cash Runway Expected to Extend Into Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890800?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA6PPXC8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2510828800","title":"Voyager Therapeutics Inc - to Assess Alternate Payloads for Sod1 ALS Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2510828800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510828800?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA6PPXC8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2510800849","title":"Voyager Therapeutics Inc - Expects Ind Filings in 2025 for Gba1 and Fa, 2026 for Vy1706","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800849?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA6PPXC8:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VYGR"],"gpt_icon":0},{"id":"2510800826","title":"Voyager Therapeutics Inc - No Longer Anticipates Ind Filing for Vy9323 in Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800826","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800826?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA6PPXC8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2510005807","title":"Voyager Provides Update on Sod1 ALS Gene Therapy Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2510005807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510005807?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nTUA6PPXC8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2509222035","title":"Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2509222035","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509222035?lang=en_us&edition=fundamental","pubTime":"2025-02-06 20:00","pubTimestamp":1738843200,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., Feb. 06, 2025  -- Voyager Therapeutics, Inc., a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will participate in a fireside chat at the Oppenheimer 25th Annual Healthcare Life Sciences Conference at 2:40 p.m. ET onFebruary 11, 2025.Voyager Therapeuticsis a registered trademark, and TRACER is a trademark, ofVoyager Therapeutics, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/voyager-present-oppenheimer-25th-annual-120000147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VYGR","BK4127","HCSG","OPY","BK4137","BK4139"],"gpt_icon":0},{"id":"2507671654","title":"What Makes Voyager Therapeutics (VYGR) a New Buy Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2507671654","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507671654?lang=en_us&edition=fundamental","pubTime":"2025-01-31 01:00","pubTimestamp":1738256413,"startTime":"0","endTime":"0","summary":"Investors might want to bet on Voyager Therapeutics , as it has been recently upgraded to a Zacks Rank #2 . This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.As such, the Zacks rating upgrade for Voyager Therapeutics is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock pri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/makes-voyager-therapeutics-vygr-buy-170013071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VYGR","BK4139"],"gpt_icon":0},{"id":"2506710883","title":"Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2506710883","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506710883?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:45","pubTimestamp":1737981900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VYGR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2025 07:45 ET (12:45 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYGR"],"gpt_icon":0},{"id":"2506893707","title":"Is it a Good Idea to Invest in Beam Therapeutics Stock Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506893707","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506893707?lang=en_us&edition=fundamental","pubTime":"2025-01-24 23:40","pubTimestamp":1737733200,"startTime":"0","endTime":"0","summary":"Beam Therapeutics BEAM is developing its lead pipeline candidate, BEAM-101, a base-editing therapy, in the phase I/II BEACON study for treating sickle cell disease , an inherited blood disorder.BEAM’s pipeline of gene editing therapies is based on its proprietary base editing technology.The company believes that its innovative next-generation technology called base-editing technology can provide a superior way to modify genes and could open up entirely new applications in gene editing, targeting a wide range of severe diseases. It can also make more precise single-base changes at specific locations in genes, resulting in predictable edits in all cells, without needing to damage or make double-stranded breaks in the DNA.Beam Therapeutics currently has a Zacks Rank #2 . In the past 60 days, estimates for BEAM’s 2025 loss per share have narrowed from $4.62 to $4.32.In the past 60 days, estimates for Voyager Therapeutics’ loss per share have narrowed from $1.72 to $1.58 for 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/good-idea-invest-beam-therapeutics-154000464.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4556","BK4505","HRMY","BK4196","LENZ","SCD","BK4139","BEAM","CSTL","VYGR","BK4585","BK4535","BK4007","BK4588"],"gpt_icon":0},{"id":"2505017911","title":"NTLA Begins Dosing in Pivotal Study on Hereditary Angioedema Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2505017911","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505017911?lang=en_us&edition=fundamental","pubTime":"2025-01-23 21:56","pubTimestamp":1737640560,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics NTLA announced that it has dosed the first patient in the phase III HAELO study evaluating NTLA-2002, its novel in vivo CRISPRgene editing therapy for the treatment of hereditary angioedema .Shares of the company were up 10.8% on Jan. 22 following the announcement of the news.The global double-blind, placebo-controlled HAELO study will evaluate the safety and efficacy of NTLA-2002 in adults with Type I or Type II HAE. The key endpoint of the study is to see the change in the number of HAE attacks from week five through week 28 of treatment.Enrollment of patients in the study is expected to be completed in the second half of 2025. Intellia plans to submit a biologics license application for NTLA-2002 in HAE in 2026. Upon potential approval, the company plans to launch NTLA-2002 in 2027 in the United States.Despite the current treatment options that require chronic administration for disease control, HAE attacks still occur. NTLA-2002 aims to prevent HAE attacks by ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ntla-begins-dosing-pivotal-study-135600627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4556","BK4535","HAE","LU1169590202.USD","LU1974910355.USD","VYGR","LU1917777945.USD","BK4585","LU2362541273.HKD","LU0109394709.USD","LU2089984988.USD","LU2362541513.USD","LU2468319806.SGD","LU1861559042.SGD","BK4139","BK4588","NTLA","LU0012050646.USD","BK4198","REGN","LU0053666078.USD","LU0320765992.SGD","CSTL","IE00B64QTZ34.USD","LU2237438978.USD","LU1169589451.USD","LU0882574055.USD","LU0114720955.EUR","LU0823416689.USD","LU0289739699.SGD","IE00BLDYK493.USD","LU0205194284.USD","LU0106261612.USD","LU1861558580.USD","LU0205193047.USD","LU2023250504.SGD","BK4196","LU2106854487.HKD","LU2362540622.SGD","LU0889565916.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2505779089","title":"REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2505779089","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505779089?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:37","pubTimestamp":1737563820,"startTime":"0","endTime":"0","summary":"Replimune Group, Inc. REPL announced that the FDA has accepted the biologics license application  for its lead pipeline candidate, RP1 , in combination with Bristol Myers’ BMY Opdivo  to treat adult patients with advanced melanoma.With the FDA granting a priority review to the BLA, a decision from the regulatory body is expected on July 22, 2025.Shares of REPL were up 16.9% on Jan. 21 following the announcement of the news.The FDA also informed REPL that the agency is not currently planning to hold an advisory committee meeting related to the BLA, as it has not identified any potential review issues at this point.In the past year, shares of Replimune have rallied 50.7% against the industry’s decline of 14.8%.Replimune submitted the BLA for the RP1/Opdivo combo in advanced melanoma in November 2024.In the past 60 days, estimates for Voyager Therapeutics’ loss per share have narrowed from $1.72 to $1.48 for 2025. In the past year, shares of VYGR have plunged 30.9%.In the past 60 days, es","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/repl-stock-rises-fdas-priority-163700715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4581","LU1868836757.USD","LU0225771236.USD","LU2125154935.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1430594728.SGD","LU2242646821.SGD","IE00B2B36J28.USD","LU1670710661.SGD","BK4196","LU0061475181.USD","LU2125154778.USD","LU0321505439.SGD","LU2133065610.SGD","LU0237698245.USD","LU0321505868.SGD","LU1323610961.USD","IE00BJT1NW94.SGD","LU2242652126.USD","VYGR","LU1868837300.USD","LU0114720955.EUR","LU0868494617.USD","CSTL","LU0306807586.USD","LU1868837136.USD","BK4588","LU1291159041.SGD","LU1670711123.USD","IE00BSNM7G36.USD","LU1868836914.USD","REPL","LU0882574055.USD","LU0225284248.USD","LU1571399168.USD","BK4534","LU0456855351.SGD","LU1261432733.SGD","LU1989771016.USD","LU2360032135.SGD","IE0002141913.USD","LU1032466523.USD","BMY","LU0306806265.USD","BK4139","LU1093756325.SGD","LU1868836591.USD","LU1670710588.SGD"],"gpt_icon":0},{"id":"2505727779","title":"J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2505727779","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505727779?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:15","pubTimestamp":1737562500,"startTime":"0","endTime":"0","summary":"Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application , seeking approval for Spravato  as a monotherapy for adults living with treatment-resistant depression .Spravato is presently approved in combination with an oral antidepressant to treat adults with TRD and depressive symptoms in adults with major depressive disorder  with acute suicidal ideation or behavior.Following the latest nod, Spravato became the first and only monotherapy for treating MDD in adults who have had an inadequate response to at least two oral antidepressants and are considered to have TRD.In the past year, shares of J&J have lost 7.3% compared with the industry’s decline of 5.1%.More on the Latest Nod for JNJ's Spravato as Monotherapy. The latest FDA nod for Spravato was based on data from a double-blind, multicenter, placebo-controlled study.In the past 60 days, estimates for BioMarin’s earnings per share have increased from $3.94 to $4.02 for 2025. In the past year, sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/j-js-depression-drug-spravato-161500318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0034235303.USD","IE00BVYPNW00.USD","BK4559","LU0122379950.USD","IE00BVYPNV92.GBP","LU0234572021.USD","LU0912757837.SGD","LU1585245621.USD","LU0795875086.SGD","JNJ","LU1066051225.USD","SG9999002232.USD","IE00BGHQF631.EUR","BK4566","LU2602419157.SGD","LU0882574055.USD","LU1221951129.SGD","LU1066051811.HKD","BK4532","LU2468319806.SGD","LU0114720955.EUR","LU2133065610.SGD","LU1430594728.SGD","LU0203347892.USD","LU2089984988.USD","LU1732799900.SGD","LU1244550494.USD","IE00B19Z3581.USD","BK4504","IE00BFTCPJ56.SGD","LU0792757196.USD","LU1280957306.USD","LU1929549753.HKD","LU1506573853.SGD","LU1732800096.USD","LU0345770308.USD","BK4550","LU1261432733.SGD","BK4534","LU0795875169.SGD","IE0009355771.USD","VYGR","LU0289739699.SGD","LU1718418525.SGD","BK4139","CSTL","BMRN","IE00BJT1NW94.SGD","LU1066051498.USD","LU0234570918.USD"],"gpt_icon":1},{"id":"2505287123","title":"Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505287123","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505287123?lang=en_us&edition=fundamental","pubTime":"2025-01-20 22:18","pubTimestamp":1737382680,"startTime":"0","endTime":"0","summary":"Amgen AMGN announced that the FDA has approved its KRAS inhibitor, Lumakras , in combination with its anti-EGFR antibody, Vectibix , for treating KRAS G12C-mutated metastatic colorectal cancer .The regulatory body approved Lumakras plus Vectibix for treating KRAS G12C-mutated mCRC in adult patients who have previously received fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy.Lumakras is presently approved for treating advanced or metastatic non-small cell lung cancer . The drug was approved in the United States in May 2021 and in the EU  in January 2022.In the past year, shares of Amgen have dropped 12.2% compared with the industry’s decline of 14.1%.Lumakras’ approval for the mCRC indication was based on data from the phase III CodeBreaK 300 study, which evaluated Lumakras plus Vectibix versus the investigator's choice of therapy in KRAS G12C–mutated mCRC.Data from the CodeBreaK 300 study also showed that treatment with Lumakras plus Vectibix demonstrated favorable ov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgens-lumakras-gets-fda-nod-141800343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","IE00BFTCPJ56.SGD","BK4213","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2242646821.SGD","BK4599","IE00BJT1NW94.SGD","SOC","BK4195","IE00B2B36J28.USD","LU0058720904.USD","LU2112291526.USD","BK4211","VYGR","BK4588","BK4566","LU2242652126.USD","CSTL","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0320765992.SGD","IE0002141913.USD","LU0868494617.USD","BK4534","LU0122379950.USD","BK4139","PFS","BK4585","AMGN","LU0889565916.HKD","LU1057294990.SGD","SG9999001440.SGD","LU1061106388.HKD","LU1983299246.USD","IE0009355771.USD","LU0289739699.SGD","LU1571399168.USD","CTMX","BK4581","BK4533"],"gpt_icon":0},{"id":"2504929191","title":"Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2504929191","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504929191?lang=en_us&edition=fundamental","pubTime":"2025-01-17 23:28","pubTimestamp":1737127680,"startTime":"0","endTime":"0","summary":"Massachusett-based Stoke Therapeutics STOK is making rapid progress with the development of zorevunersen , its investigational candidate for treating Dravet syndrome, a severe and progressive genetic epilepsy.Zorevunersen is a novel proprietary antisense oligonucleotide with the potential to become the first disease-modifying therapy to address the genetic cause of Dravet syndrome.The FDA granted a Breakthrough Therapy designation to zorevunersen for treating Dravet syndrome in December 2024.In the past year, shares of Stoke Therapeutics have rallied 94.7% against the industry’s decline of 13.6%.In the past 60 days, estimates for Voyager Therapeutics’ loss per share have narrowed from $1.72 to $1.48 for 2025. In the past year, shares of VYGR have plunged 30.6%.In the past 60 days, estimates for CytomX Therapeutics’ loss per share have narrowed from 46 cents to 35 cents for 2025. In the past year, shares of CTMX have decreased 49.5%.CTMX’s earnings beat estimates in two of the trailing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/good-idea-invest-stoke-therapeutics-152800824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CTMX","STOK","CSTL","VYGR","BK4196","LENZ","BK4139"],"gpt_icon":0},{"id":"2504949490","title":"MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2504949490","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504949490?lang=en_us&edition=fundamental","pubTime":"2025-01-17 01:09","pubTimestamp":1737047340,"startTime":"0","endTime":"0","summary":"Shares of Mirum Pharmaceuticals MIRM were up 12.1% this week, driven by investor enthusiasm after the company announced encouraging preliminary sales numbers for the fourth quarter and full year 2024, along with an encouraging outlook and growth strategy for 2025.Mirum’s commercial portfolio comprises of lead product, Livmarli , which is approved for treating cholestatic pruritus in patients with Alagille syndrome worldwide. The drug is also approved for treating certain patients with progressive familial intrahepatic cholestasis in the United States and Europe.MIRM acquired Travere Therapeutics’ bile acid products in August 2023, which added the latter’s Cholbam capsules and Chenodal tablets to its portfolio of commercialized drugs.In the past year, shares of Mirum have rallied 73.3% against the industry’s decline of 16%.Meanwhile, a new drug application seeking approval for Chenodiol for cerebrotendinous xanthomatosis  patients is currently under review in the United States. A decisi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mirm-shares-rise-12-week-170900763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MIRM","BK4196","VYGR","BK4139","CSTL","CTMX"],"gpt_icon":0},{"id":"2503273621","title":"TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2503273621","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503273621?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:10","pubTimestamp":1736950200,"startTime":"0","endTime":"0","summary":"TG Therapeutics TGTX announced preliminary net product revenues for the fourth quarter and full-year 2024 for its marketed drug, Briumvi , which exceeded the company’s initial expectations.TGTX also provided its guidance for 2025 and outlined some expected milestones related to Briumvi label expansion studies and other pipeline candidates for 2025.Briumvi is approved for the treatment of certain adult patients with relapsing forms of multiple sclerosis .In the past year, shares of TG Therapeutics have rallied 96.2% against the industry’s decline of 14.8%.In the past 60 days, estimates for Voyager Therapeutics’ loss per share have narrowed from $1.72 to $1.48 for 2025. In the past year, shares of VYGR have plunged 33%.In the past 60 days, estimates for CytomX Therapeutics’ loss per share have narrowed from 46 cents to 35 cents for 2025. In the past year, shares of CTMX have plunged 49.5%.CTMX’s earnings beat estimates in two of the trailing four quarters while missing the same on the re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tgtx-announces-2024-preliminary-results-141000241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BK4585","LU0267386448.USD","LU0912757837.SGD","BK4581","TGTX","LU1720051108.HKD","LU0158827781.USD","LU0098860793.USD","LU1989772923.USD","BK4516","BK4534","LU1074936037.SGD","BK4504","LU2111349929.HKD","LU0795875086.SGD","LU1162221912.USD","LU1548497426.USD","LU1720051017.SGD","LU2028103732.USD","LU2357305700.SGD","LU1732800096.USD","LU2271345857.HKD","CSTL","LU2089284900.SGD","LU0158827948.USD","IE00BKVL7J92.USD","BK4139","LU0006306889.USD","LU0106831901.USD","LU0795875169.SGD","LU1732799900.SGD","LU0320765646.SGD","LU0971096721.USD","BK4588","LU0314104364.USD","LU0225283273.USD","LU1363072403.SGD","CTMX","LU2023251221.USD","IE00BZ1G4Q59.USD","LU2089283258.USD","VYGR","LU2347655156.SGD","LU1989772840.SGD","LU1668664300.SGD","LU0106261372.USD","BK4127"],"gpt_icon":0},{"id":"2503657809","title":"Oppenheimer Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503657809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503657809?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:26","pubTimestamp":1736861208,"startTime":"0","endTime":"0","summary":"In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), with a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-voyager-therapeutics-vygr-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-voyager-therapeutics-vygr-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYGR","OPY"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":100,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VYGR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"VYGR","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2024-11-12","symbol":"VYGR","fiscalQuarterEnding":"2024/09","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2024-08-06","symbol":"VYGR","fiscalQuarterEnding":"2024/06","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-05-13","symbol":"VYGR","fiscalQuarterEnding":"2024/03","expectedEps":-0.44,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2024-02-28","symbol":"VYGR","fiscalQuarterEnding":"2023/12","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VYGR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VYGR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":12,"updateTime":1736568000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VYGR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VYGR","date":"2025-05-02","current":-3.015052,"percent":0.381803,"low":-159.750011,"twenty":-7.117115,"median":3.174613,"eighty":7.473905,"high":49.372028,"avg":-2.702473,"sd":29.472375,"marketCap":195984441},"quantilePoints":[{"date":"2020-05-08","current":-10.191109,"twenty":-12.930916,"median":-9.918622,"eighty":-8.054736,"marketCap":414676215},{"date":"2020-05-15","current":-10.858329,"twenty":-12.915342,"median":-9.929904,"eighty":-8.059163,"marketCap":441825420},{"date":"2020-05-22","current":-11.87287,"twenty":-12.907176,"median":-9.952809,"eighty":-8.061025,"marketCap":483107089},{"date":"2020-05-29","current":-11.05941,"twenty":-12.906456,"median":-9.981036,"eighty":-8.069229,"marketCap":450007373},{"date":"2020-06-05","current":-10.986289,"twenty":-12.898661,"median":-10.02394,"eighty":-8.082069,"marketCap":447032117},{"date":"2020-06-12","current":-11.08683,"twenty":-12.882764,"median":-10.036662,"eighty":-8.085675,"marketCap":451123093},{"date":"2020-06-19","current":-12.19277,"twenty":-12.875244,"median":-10.074514,"eighty":-8.100628,"marketCap":496123831},{"date":"2020-06-26","current":-11.66265,"twenty":-12.875244,"median":-10.126119,"eighty":-8.117176,"marketCap":474553229},{"date":"2020-07-02","current":-11.79061,"twenty":-12.870642,"median":-10.144261,"eighty":-8.120588,"marketCap":479759926},{"date":"2020-07-10","current":-11.79975,"twenty":-12.854507,"median":-10.191109,"eighty":-8.131646,"marketCap":480131833},{"date":"2020-07-17","current":-11.86373,"twenty":-12.848393,"median":-10.235326,"eighty":-8.131785,"marketCap":482735182},{"date":"2020-07-24","current":-11.013709,"twenty":-12.845453,"median":-10.249954,"eighty":-8.132688,"marketCap":448147838},{"date":"2020-07-31","current":-10.117989,"twenty":-12.83606,"median":-10.261608,"eighty":-8.135187,"marketCap":411700960},{"date":"2020-08-07","current":-10.227669,"twenty":-12.819723,"median":-10.249954,"eighty":-8.139933,"marketCap":416163843},{"date":"2020-08-14","current":-6.969924,"twenty":-12.776381,"median":-10.235326,"eighty":-8.131646,"marketCap":421847685},{"date":"2020-08-21","current":-7.384285,"twenty":-12.766514,"median":-10.212978,"eighty":-8.084273,"marketCap":446926474},{"date":"2020-08-28","current":-7.272964,"twenty":-12.753302,"median":-10.159734,"eighty":-8.0573,"marketCap":440188889},{"date":"2020-09-04","current":-6.660699,"twenty":-12.730203,"median":-10.137891,"eighty":-8.036455,"marketCap":403132171},{"date":"2020-09-11","current":-6.190678,"twenty":-12.722891,"median":-10.114347,"eighty":-7.993852,"marketCap":374684590},{"date":"2020-09-18","current":-7.180197,"twenty":-12.709282,"median":-10.06383,"eighty":-7.977181,"marketCap":434574235},{"date":"2020-09-25","current":-7.124536,"twenty":-12.68215,"median":-10.044707,"eighty":-7.967925,"marketCap":431205442},{"date":"2020-10-02","current":-6.499903,"twenty":-12.652421,"median":-10.024417,"eighty":-7.93869,"marketCap":393400104},{"date":"2020-10-09","current":-7.161643,"twenty":-12.624509,"median":-9.993512,"eighty":-7.923681,"marketCap":433451304},{"date":"2020-10-16","current":-7.594558,"twenty":-12.623714,"median":-9.952809,"eighty":-7.896071,"marketCap":459653023},{"date":"2020-10-23","current":-6.821496,"twenty":-12.622905,"median":-9.929904,"eighty":-7.871008,"marketCap":412864238},{"date":"2020-10-30","current":-6.574116,"twenty":-12.613066,"median":-9.918622,"eighty":-7.865763,"marketCap":397891827},{"date":"2020-11-06","current":-6.790574,"twenty":-12.60074,"median":-9.911417,"eighty":-7.846779,"marketCap":410992687},{"date":"2020-11-13","current":7.989734,"twenty":-12.571138,"median":-9.898205,"eighty":-7.801582,"marketCap":320332393},{"date":"2020-11-20","current":7.78415,"twenty":-12.567511,"median":-9.889367,"eighty":-7.755355,"marketCap":312089922},{"date":"2020-11-27","current":7.905631,"twenty":-12.560333,"median":-9.871642,"eighty":-7.695477,"marketCap":316960473},{"date":"2020-12-04","current":7.559877,"twenty":-12.554936,"median":-9.855363,"eighty":-7.635639,"marketCap":303098135},{"date":"2020-12-11","current":7.46643,"twenty":-12.550649,"median":-9.830518,"eighty":-7.60809,"marketCap":299351558},{"date":"2020-12-18","current":8.204662,"twenty":-12.546308,"median":-9.826851,"eighty":-7.571531,"marketCap":328949522},{"date":"2020-12-24","current":7.457085,"twenty":-12.544691,"median":-9.802208,"eighty":-7.534348,"marketCap":298976900},{"date":"2020-12-31","current":6.681473,"twenty":-12.531291,"median":-9.778187,"eighty":-7.486978,"marketCap":267880305},{"date":"2021-01-08","current":7.78415,"twenty":-12.510675,"median":-9.769156,"eighty":-7.457425,"marketCap":312089922},{"date":"2021-01-15","current":7.94301,"twenty":-12.502479,"median":-9.726268,"eighty":-7.415214,"marketCap":318459104},{"date":"2021-01-22","current":8.447625,"twenty":-12.491463,"median":-9.710692,"eighty":-7.393558,"marketCap":338690624},{"date":"2021-01-29","current":7.055262,"twenty":-12.483266,"median":-9.692736,"eighty":-7.363875,"marketCap":282866616},{"date":"2021-02-05","current":6.961815,"twenty":-12.474753,"median":-9.670746,"eighty":-7.336748,"marketCap":279120038},{"date":"2021-02-12","current":6.737542,"twenty":-12.472463,"median":-9.663952,"eighty":-7.325181,"marketCap":270128252},{"date":"2021-02-19","current":6.29834,"twenty":-12.472463,"median":-9.657041,"eighty":-7.304266,"marketCap":252519336},{"date":"2021-02-26","current":5.810867,"twenty":-12.413633,"median":-9.649189,"eighty":-7.272964,"marketCap":213497074},{"date":"2021-03-05","current":5.667389,"twenty":-12.413633,"median":-9.641982,"eighty":-7.247956,"marketCap":208225541},{"date":"2021-03-12","current":5.872358,"twenty":-12.383656,"median":-9.598199,"eighty":-7.217304,"marketCap":215756302},{"date":"2021-03-19","current":5.677637,"twenty":-12.350247,"median":-9.572931,"eighty":-7.161643,"marketCap":208602079},{"date":"2021-03-26","current":4.93975,"twenty":-12.31146,"median":-9.545385,"eighty":-7.119067,"marketCap":181491340},{"date":"2021-04-01","current":4.970495,"twenty":-12.294849,"median":-9.52816,"eighty":-7.061951,"marketCap":182620954},{"date":"2021-04-09","current":4.878259,"twenty":-12.256994,"median":-9.507203,"eighty":-6.927662,"marketCap":179232111},{"date":"2021-04-16","current":4.67329,"twenty":-12.216926,"median":-9.480087,"eighty":-6.894717,"marketCap":171701350},{"date":"2021-04-23","current":4.795477,"twenty":-12.189785,"median":-9.459143,"eighty":-6.854892,"marketCap":176190614},{"date":"2021-04-30","current":4.949507,"twenty":-12.115234,"median":-9.438273,"eighty":-6.816675,"marketCap":181849842},{"date":"2021-05-07","current":4.425804,"twenty":-12.081234,"median":-9.418995,"eighty":-6.763362,"marketCap":162608468},{"date":"2021-05-14","current":4.371503,"twenty":-12.067898,"median":-9.372056,"eighty":-6.694678,"marketCap":172040514},{"date":"2021-05-21","current":4.083904,"twenty":-12.067898,"median":-9.355106,"eighty":-6.613697,"marketCap":160722059},{"date":"2021-05-28","current":4.083904,"twenty":-12.035076,"median":-9.328115,"eighty":-6.528819,"marketCap":160722059},{"date":"2021-06-04","current":4.035971,"twenty":-12.027468,"median":-9.317833,"eighty":-6.447295,"marketCap":158835650},{"date":"2021-06-11","current":4.534476,"twenty":-11.972135,"median":-9.28322,"eighty":-6.409689,"marketCap":178454305},{"date":"2021-06-18","current":4.304397,"twenty":-11.931763,"median":-9.248607,"eighty":-6.307212,"marketCap":169399541},{"date":"2021-06-25","current":4.170184,"twenty":-11.896565,"median":-9.223583,"eighty":-6.135582,"marketCap":164117596},{"date":"2021-07-02","current":3.949692,"twenty":-11.896565,"median":-9.168388,"eighty":-6.075894,"marketCap":155440113},{"date":"2021-07-09","current":3.748372,"twenty":-11.896565,"median":-9.152492,"eighty":-5.828094,"marketCap":147517195},{"date":"2021-07-16","current":3.269041,"twenty":-11.89115,"median":-9.129511,"eighty":-5.651153,"marketCap":128653104},{"date":"2021-07-23","current":2.991029,"twenty":-11.867386,"median":-9.083399,"eighty":-5.500988,"marketCap":117711930},{"date":"2021-07-30","current":3.019788,"twenty":-11.854952,"median":-9.044139,"eighty":-5.202487,"marketCap":118843776},{"date":"2021-08-06","current":3.173175,"twenty":-11.822116,"median":-8.999393,"eighty":-5.034637,"marketCap":124880285},{"date":"2021-08-13","current":6.267555,"twenty":-11.802371,"median":-8.971703,"eighty":-4.881895,"marketCap":112289521},{"date":"2021-08-20","current":6.098162,"twenty":-11.764693,"median":-8.92811,"eighty":-4.758525,"marketCap":109254669},{"date":"2021-08-27","current":6.521645,"twenty":-11.754947,"median":-8.901533,"eighty":-4.659494,"marketCap":116841798},{"date":"2021-09-03","current":7.051,"twenty":-11.733711,"median":-8.874786,"eighty":-4.551231,"marketCap":126325711},{"date":"2021-09-10","current":6.987477,"twenty":-11.71749,"median":-8.869312,"eighty":-4.502555,"marketCap":125187641},{"date":"2021-09-17","current":6.585168,"twenty":-11.694992,"median":-8.840173,"eighty":-4.471503,"marketCap":117979868},{"date":"2021-09-24","current":6.225207,"twenty":-11.666561,"median":-8.812483,"eighty":-4.414434,"marketCap":111530808},{"date":"2021-10-01","current":5.526459,"twenty":-11.611906,"median":-8.778982,"eighty":-4.025864,"marketCap":99012043},{"date":"2021-10-08","current":11.751666,"twenty":-11.578997,"median":-8.760311,"eighty":-3.949492,"marketCap":210542851},{"date":"2021-10-15","current":8.681411,"twenty":-11.561942,"median":-8.725005,"eighty":-3.86221,"marketCap":155536160},{"date":"2021-10-22","current":8.025012,"twenty":-11.508908,"median":-8.697865,"eighty":-3.713664,"marketCap":143776109},{"date":"2021-10-29","current":7.665051,"twenty":-11.493526,"median":-8.68144,"eighty":-3.558404,"marketCap":137327049},{"date":"2021-11-05","current":-1.553754,"twenty":-11.477233,"median":-8.656385,"eighty":-3.367055,"marketCap":144238104},{"date":"2021-11-12","current":-1.382023,"twenty":-11.461658,"median":-8.642118,"eighty":-1.524314,"marketCap":128295998},{"date":"2021-11-19","current":-1.345224,"twenty":-11.421685,"median":-8.610688,"eighty":-1.398379,"marketCap":124879832},{"date":"2021-11-26","current":-1.251181,"twenty":-11.392291,"median":-8.598427,"eighty":-1.335411,"marketCap":116149631},{"date":"2021-12-03","current":-1.083539,"twenty":-11.357441,"median":-8.53994,"eighty":-1.245456,"marketCap":100587099},{"date":"2021-12-10","current":-1.202115,"twenty":-11.339724,"median":-8.51494,"eighty":-1.216835,"marketCap":111594744},{"date":"2021-12-17","current":-1.222559,"twenty":-11.29916,"median":-8.485963,"eighty":-1.190666,"marketCap":113492614},{"date":"2021-12-23","current":-1.198026,"twenty":-11.267549,"median":-8.473312,"eighty":-1.182489,"marketCap":111215170},{"date":"2021-12-31","current":-1.108072,"twenty":-11.218293,"median":-8.456811,"eighty":-1.1416,"marketCap":102864543},{"date":"2022-01-07","current":-1.144871,"twenty":-11.181633,"median":-8.437836,"eighty":-1.135876,"marketCap":106280708},{"date":"2022-01-14","current":-1.202115,"twenty":-11.127759,"median":-8.411313,"eighty":-1.135876,"marketCap":111594744},{"date":"2022-01-21","current":-1.157138,"twenty":-11.10683,"median":-8.366872,"eighty":-1.135876,"marketCap":107419430},{"date":"2022-01-28","current":-1.153049,"twenty":-11.05966,"median":-8.330789,"eighty":-1.135876,"marketCap":107039856},{"date":"2022-02-04","current":-1.32478,"twenty":-11.01409,"median":-8.297694,"eighty":-1.135876,"marketCap":122981963},{"date":"2022-02-11","current":-1.361579,"twenty":-10.954227,"median":-8.269233,"eighty":-1.135876,"marketCap":126398128},{"date":"2022-02-18","current":-1.39429,"twenty":-10.906262,"median":-8.245428,"eighty":-1.135876,"marketCap":129434720},{"date":"2022-02-25","current":-1.553754,"twenty":-10.830935,"median":-8.222928,"eighty":-1.135876,"marketCap":144238104},{"date":"2022-03-04","current":-1.512866,"twenty":-10.797566,"median":-8.195593,"eighty":-1.135876,"marketCap":140442365},{"date":"2022-03-11","current":-2.992557,"twenty":-10.766867,"median":-8.181696,"eighty":-1.135876,"marketCap":213061061},{"date":"2022-03-18","current":-4.170307,"twenty":-10.720427,"median":-8.15759,"eighty":-1.135876,"marketCap":296913357},{"date":"2022-03-25","current":-5.05362,"twenty":-10.663194,"median":-8.131995,"eighty":-1.135876,"marketCap":359802579},{"date":"2022-04-01","current":-4.459391,"twenty":-10.606164,"median":-8.086377,"eighty":-1.135876,"marketCap":317495284},{"date":"2022-04-08","current":-4.475452,"twenty":-10.545726,"median":-8.054328,"eighty":-1.135876,"marketCap":318638724},{"date":"2022-04-14","current":-4.775243,"twenty":-10.499233,"median":-8.032465,"eighty":-1.135876,"marketCap":339982945},{"date":"2022-04-22","current":-4.034644,"twenty":-10.466512,"median":-7.98153,"eighty":-1.135876,"marketCap":287254537},{"date":"2022-04-29","current":-3.953735,"twenty":-10.448659,"median":-7.970553,"eighty":-1.135876,"marketCap":281494085},{"date":"2022-05-06","current":-3.369864,"twenty":-10.432928,"median":-7.937843,"eighty":-1.135876,"marketCap":238812176},{"date":"2022-05-13","current":-3.500101,"twenty":-10.386098,"median":-7.913822,"eighty":-1.135876,"marketCap":248041632},{"date":"2022-05-20","current":-3.451262,"twenty":-10.365829,"median":-7.877338,"eighty":-1.135876,"marketCap":244580586},{"date":"2022-05-27","current":-3.28304,"twenty":-10.320269,"median":-7.866434,"eighty":-1.135876,"marketCap":232659205},{"date":"2022-06-03","current":-3.510954,"twenty":-10.283407,"median":-7.85201,"eighty":-1.135876,"marketCap":248810753},{"date":"2022-06-10","current":-2.930317,"twenty":-10.229801,"median":-7.799584,"eighty":-1.135876,"marketCap":207662761},{"date":"2022-06-17","current":-2.713256,"twenty":-10.138308,"median":-7.715308,"eighty":-1.135876,"marketCap":192280335},{"date":"2022-06-24","current":-3.125671,"twenty":-10.04818,"median":-7.649484,"eighty":-1.135058,"marketCap":221506945},{"date":"2022-07-01","current":-3.29932,"twenty":-10.012746,"median":-7.609951,"eighty":-1.135058,"marketCap":233812887},{"date":"2022-07-08","current":-3.565219,"twenty":-9.951687,"median":-7.576004,"eighty":-1.135058,"marketCap":252656360},{"date":"2022-07-15","current":-3.722588,"twenty":-9.917533,"median":-7.49733,"eighty":-1.135058,"marketCap":263808619},{"date":"2022-07-22","current":-3.386144,"twenty":-9.89798,"median":-7.458499,"eighty":-1.135058,"marketCap":239965858},{"date":"2022-07-29","current":-3.635763,"twenty":-9.86971,"median":-7.414099,"eighty":-1.135058,"marketCap":257655648},{"date":"2022-08-05","current":-4.476181,"twenty":-9.830518,"median":-7.384285,"eighty":-1.135058,"marketCap":267827812},{"date":"2022-08-12","current":-3.920695,"twenty":-9.830518,"median":-7.337967,"eighty":-1.135058,"marketCap":234590883},{"date":"2022-08-19","current":-3.759217,"twenty":-9.830518,"median":-7.324377,"eighty":-1.135058,"marketCap":224928985},{"date":"2022-08-26","current":-3.907777,"twenty":-9.830518,"median":-7.291518,"eighty":-1.135058,"marketCap":233817931},{"date":"2022-09-02","current":-4.275948,"twenty":-9.830518,"median":-7.260022,"eighty":-1.135058,"marketCap":255847059},{"date":"2022-09-09","current":-4.418049,"twenty":-9.786044,"median":-7.233718,"eighty":-1.135058,"marketCap":264349529},{"date":"2022-09-16","current":-4.243652,"twenty":-9.739392,"median":-7.161643,"eighty":-1.135058,"marketCap":253914679},{"date":"2022-09-23","current":-3.597739,"twenty":-9.693777,"median":-7.119246,"eighty":-1.135058,"marketCap":215267087},{"date":"2022-09-30","current":-3.823808,"twenty":-9.65855,"median":-7.058991,"eighty":-1.135058,"marketCap":228793744},{"date":"2022-10-07","current":-4.017582,"twenty":-9.643735,"median":-6.926633,"eighty":-1.135058,"marketCap":240388022},{"date":"2022-10-14","current":-3.707544,"twenty":-9.590163,"median":-6.883949,"eighty":-1.135058,"marketCap":221837178},{"date":"2022-10-21","current":-3.403964,"twenty":-9.547664,"median":-6.849326,"eighty":-1.135058,"marketCap":203672809},{"date":"2022-10-28","current":-3.43626,"twenty":-9.527698,"median":-6.815312,"eighty":-1.135058,"marketCap":205605189},{"date":"2022-11-04","current":-3.223109,"twenty":-9.508951,"median":-6.741098,"eighty":-1.135058,"marketCap":192851484},{"date":"2022-11-11","current":-12.414592,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":211954329},{"date":"2022-11-18","current":-12.211074,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":208479668},{"date":"2022-11-25","current":-12.459818,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":212726476},{"date":"2022-12-02","current":-14.58545,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":249017381},{"date":"2022-12-09","current":-13.386955,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":228555488},{"date":"2022-12-16","current":-13.409568,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":228941561},{"date":"2022-12-23","current":-12.572884,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":214656843},{"date":"2022-12-30","current":-13.793991,"twenty":-9.501574,"median":-6.729095,"eighty":-1.135058,"marketCap":235504810},{"date":"2023-01-06","current":-15.738718,"twenty":-9.518946,"median":-6.729095,"eighty":-1.135058,"marketCap":268707128},{"date":"2023-01-13","current":-24.376922,"twenty":-9.540905,"median":-6.729095,"eighty":-1.135058,"marketCap":416187189},{"date":"2023-01-20","current":-20.7136,"twenty":-9.561509,"median":-6.729095,"eighty":-1.135058,"marketCap":353643289},{"date":"2023-01-27","current":-20.374403,"twenty":-9.597507,"median":-6.729095,"eighty":-1.135058,"marketCap":347852187},{"date":"2023-02-03","current":-18.316611,"twenty":-9.647123,"median":-6.729095,"eighty":-1.135058,"marketCap":312719502},{"date":"2023-02-10","current":-17.4347,"twenty":-9.662069,"median":-6.729095,"eighty":-1.135058,"marketCap":297662637},{"date":"2023-02-17","current":-16.801533,"twenty":-9.699403,"median":-6.729095,"eighty":-1.135058,"marketCap":286852580},{"date":"2023-02-24","current":-17.858068,"twenty":-9.699403,"median":-6.729095,"eighty":-1.135058,"marketCap":304890802},{"date":"2023-03-03","current":-18.412197,"twenty":-9.699403,"median":-6.729095,"eighty":-1.135058,"marketCap":314351447},{"date":"2023-03-10","current":-7.015302,"twenty":-9.667718,"median":-6.729095,"eighty":-1.135058,"marketCap":325566134},{"date":"2023-03-17","current":-7.388456,"twenty":-9.649003,"median":-6.729095,"eighty":-1.135058,"marketCap":342883482},{"date":"2023-03-24","current":-6.875369,"twenty":-9.649003,"median":-6.729095,"eighty":-1.135058,"marketCap":319072129},{"date":"2023-03-31","current":-7.19255,"twenty":-9.648631,"median":-6.724592,"eighty":-1.135876,"marketCap":333791874},{"date":"2023-04-06","current":-7.183221,"twenty":-9.648631,"median":-6.724592,"eighty":-1.135876,"marketCap":333358941},{"date":"2023-04-14","current":-7.547047,"twenty":-9.649003,"median":-6.720089,"eighty":-1.135058,"marketCap":350243355},{"date":"2023-04-21","current":-7.407114,"twenty":-9.649003,"median":-6.720089,"eighty":-1.135058,"marketCap":343749349},{"date":"2023-04-28","current":-6.826249,"twenty":-9.649003,"median":-6.720089,"eighty":-1.135058,"marketCap":316792577},{"date":"2023-05-05","current":-7.341969,"twenty":-9.649003,"median":-6.710175,"eighty":-1.135058,"marketCap":340726083},{"date":"2023-05-12","current":4.34473,"twenty":-9.649003,"median":-6.660699,"eighty":-1.095805,"marketCap":429932784},{"date":"2023-05-19","current":5.398229,"twenty":-9.649003,"median":-6.574116,"eighty":3.037044,"marketCap":534181799},{"date":"2023-05-26","current":5.253045,"twenty":-9.649003,"median":-6.499903,"eighty":3.157836,"marketCap":519815052},{"date":"2023-06-02","current":5.169454,"twenty":-9.649375,"median":-6.446512,"eighty":3.200017,"marketCap":511543288},{"date":"2023-06-09","current":5.627005,"twenty":-9.621606,"median":-6.407854,"eighty":3.343817,"marketCap":556820311},{"date":"2023-06-16","current":5.794188,"twenty":-9.621606,"median":-6.305312,"eighty":3.664737,"marketCap":573363838},{"date":"2023-06-23","current":5.451024,"twenty":-9.594046,"median":-6.15285,"eighty":3.853826,"marketCap":539406071},{"date":"2023-06-30","current":5.033068,"twenty":-9.572931,"median":-6.094665,"eighty":3.949692,"marketCap":498047252},{"date":"2023-07-07","current":4.681105,"twenty":-9.572931,"median":-5.85335,"eighty":4.016798,"marketCap":463218773},{"date":"2023-07-14","current":4.188357,"twenty":-9.572931,"median":-5.677297,"eighty":4.074318,"marketCap":414458902},{"date":"2023-07-21","current":3.968381,"twenty":-9.572931,"median":-5.523517,"eighty":4.112664,"marketCap":392691102},{"date":"2023-07-28","current":3.814397,"twenty":-9.572931,"median":-5.397663,"eighty":4.112664,"marketCap":377453643},{"date":"2023-08-04","current":4.26481,"twenty":-9.572931,"median":-5.117561,"eighty":4.170184,"marketCap":408713831},{"date":"2023-08-11","current":4.182354,"twenty":-9.572931,"median":-5.018792,"eighty":4.179558,"marketCap":400811738},{"date":"2023-08-18","current":4.164031,"twenty":-9.572931,"median":-4.880216,"eighty":4.188357,"marketCap":399055717},{"date":"2023-08-25","current":4.374752,"twenty":-9.572931,"median":-4.831995,"eighty":4.218117,"marketCap":419249956},{"date":"2023-09-01","current":4.590054,"twenty":-9.572931,"median":-4.779473,"eighty":4.276348,"marketCap":439883200},{"date":"2023-09-08","current":4.219001,"twenty":-9.572931,"median":-4.699778,"eighty":4.278553,"marketCap":404323779},{"date":"2023-09-15","current":3.760912,"twenty":-9.572931,"median":-4.642739,"eighty":4.278553,"marketCap":360423260},{"date":"2023-09-22","current":3.541029,"twenty":-9.572931,"median":-4.577627,"eighty":4.278553,"marketCap":339351011},{"date":"2023-09-29","current":3.536449,"twenty":-9.572931,"median":-4.528937,"eighty":4.278553,"marketCap":338912006},{"date":"2023-10-06","current":3.298242,"twenty":-9.572931,"median":-4.502555,"eighty":4.278553,"marketCap":316083736},{"date":"2023-10-13","current":3.334889,"twenty":-9.572931,"median":-4.478493,"eighty":4.278553,"marketCap":319595778},{"date":"2023-10-20","current":3.197463,"twenty":-9.572931,"median":-4.46209,"eighty":4.278553,"marketCap":306425622},{"date":"2023-10-27","current":3.014227,"twenty":-9.583939,"median":-4.427023,"eighty":4.282556,"marketCap":288865415},{"date":"2023-11-03","current":2.954675,"twenty":-9.583939,"median":-4.401846,"eighty":4.282556,"marketCap":283158347},{"date":"2023-11-10","current":5.366006,"twenty":-9.583939,"median":-4.295325,"eighty":4.319781,"marketCap":280690415},{"date":"2023-11-17","current":5.508987,"twenty":-9.583939,"median":-4.239612,"eighty":4.350759,"marketCap":288169627},{"date":"2023-11-24","current":5.744486,"twenty":-9.583939,"median":-4.18552,"eighty":4.385746,"marketCap":300488329},{"date":"2023-12-01","current":6.106145,"twenty":-9.583939,"median":-4.112306,"eighty":4.433652,"marketCap":319406335},{"date":"2023-12-08","current":6.610785,"twenty":-9.580269,"median":-4.046751,"eighty":4.498901,"marketCap":345803553},{"date":"2023-12-15","current":6.560321,"twenty":-9.580269,"median":-3.997546,"eighty":4.553158,"marketCap":343163831},{"date":"2023-12-22","current":6.854694,"twenty":-9.580269,"median":-3.983755,"eighty":4.597945,"marketCap":358562208},{"date":"2023-12-29","current":7.409798,"twenty":-9.583939,"median":-3.985287,"eighty":4.634638,"marketCap":387599148},{"date":"2024-01-05","current":9.562968,"twenty":-9.587608,"median":-3.988517,"eighty":4.685223,"marketCap":500229295},{"date":"2024-01-12","current":9.436567,"twenty":-9.587608,"median":-3.988517,"eighty":4.779874,"marketCap":493617360},{"date":"2024-01-19","current":8.587276,"twenty":-9.591277,"median":-3.991746,"eighty":4.827017,"marketCap":449191797},{"date":"2024-01-26","current":8.976534,"twenty":-9.587608,"median":-3.988517,"eighty":4.888507,"marketCap":469553513},{"date":"2024-02-02","current":8.917555,"twenty":-9.587608,"median":-3.950133,"eighty":4.935651,"marketCap":466468405},{"date":"2024-02-09","current":8.82319,"twenty":-9.587608,"median":-3.936844,"eighty":4.992306,"marketCap":461532231},{"date":"2024-02-16","current":9.0709,"twenty":-9.587608,"median":-3.91564,"eighty":5.048369,"marketCap":474489687},{"date":"2024-02-23","current":9.094491,"twenty":-9.587608,"median":-3.891629,"eighty":5.168606,"marketCap":475723730},{"date":"2024-03-01","current":3.879408,"twenty":-9.583939,"median":-3.856104,"eighty":5.19849,"marketCap":513362054},{"date":"2024-03-08","current":3.873633,"twenty":-9.583939,"median":-3.793132,"eighty":5.19849,"marketCap":512597918},{"date":"2024-03-15","current":3.746427,"twenty":-9.583939,"median":-3.746299,"eighty":5.19849,"marketCap":495764724},{"date":"2024-03-22","current":3.85722,"twenty":-9.583939,"median":-3.711735,"eighty":5.19849,"marketCap":510425893},{"date":"2024-03-28","current":3.922875,"twenty":-9.583939,"median":-3.652043,"eighty":5.19849,"marketCap":519113994},{"date":"2024-04-05","current":3.746427,"twenty":-9.587608,"median":-3.619484,"eighty":5.19937,"marketCap":495764724},{"date":"2024-04-12","current":3.602807,"twenty":-9.587608,"median":-3.570645,"eighty":5.19937,"marketCap":476759505},{"date":"2024-04-19","current":3.098086,"twenty":-9.587608,"median":-3.529946,"eighty":5.19937,"marketCap":409969733},{"date":"2024-04-26","current":3.04966,"twenty":-9.583939,"median":-3.489248,"eighty":5.19849,"marketCap":403561453},{"date":"2024-05-03","current":3.505876,"twenty":-9.583939,"median":-3.43626,"eighty":5.19849,"marketCap":463932506},{"date":"2024-05-10","current":3.468885,"twenty":-9.569193,"median":-3.403964,"eighty":5.19849,"marketCap":459037555},{"date":"2024-05-17","current":-154.210581,"twenty":-9.621606,"median":-3.403964,"eighty":5.19849,"marketCap":469417009},{"date":"2024-05-24","current":-144.739943,"twenty":-9.657041,"median":-3.403964,"eighty":5.19849,"marketCap":440588386},{"date":"2024-05-31","current":-145.454708,"twenty":-9.676033,"median":-3.403964,"eighty":5.19849,"marketCap":442764131},{"date":"2024-06-07","current":-151.530212,"twenty":-9.717961,"median":-3.403964,"eighty":5.19849,"marketCap":461257965},{"date":"2024-06-14","current":-157.248333,"twenty":-9.773612,"median":-3.397505,"eighty":5.19937,"marketCap":478663926},{"date":"2024-06-21","current":-139.200513,"twenty":-9.774726,"median":-3.391046,"eighty":5.20025,"marketCap":423726362},{"date":"2024-06-28","current":-140.451352,"twenty":-9.760972,"median":-3.379396,"eighty":5.203825,"marketCap":427533916},{"date":"2024-07-05","current":-138.128365,"twenty":-9.760972,"median":-3.379396,"eighty":5.203825,"marketCap":420462744},{"date":"2024-07-12","current":-159.750011,"twenty":-9.760972,"median":-3.379396,"eighty":5.203825,"marketCap":486279034},{"date":"2024-07-15","current":-156.712259,"twenty":-9.760972,"median":-3.379396,"eighty":5.203825,"marketCap":477032117},{"date":"2024-08-02","current":-155.104038,"twenty":-9.783846,"median":-3.329822,"eighty":5.247568,"marketCap":472136691},{"date":"2024-08-09","current":43.878025,"twenty":-9.81406,"median":-3.326452,"eighty":5.283167,"marketCap":395911424},{"date":"2024-08-16","current":39.224295,"twenty":-9.752788,"median":-3.28304,"eighty":5.372451,"marketCap":353920818},{"date":"2024-08-23","current":40.31218,"twenty":-9.697371,"median":-3.223348,"eighty":5.468616,"marketCap":363736804},{"date":"2024-08-30","current":39.466048,"twenty":-9.657796,"median":-3.125671,"eighty":5.562571,"marketCap":356102148},{"date":"2024-09-06","current":38.317725,"twenty":-9.643237,"median":-3.076833,"eighty":5.628933,"marketCap":345740830},{"date":"2024-09-13","current":37.592468,"twenty":-9.565455,"median":-2.876052,"eighty":5.677637,"marketCap":339196839},{"date":"2024-09-20","current":38.196849,"twenty":-9.530861,"median":-2.713256,"eighty":5.708684,"marketCap":344650165},{"date":"2024-09-27","current":35.598012,"twenty":-9.497821,"median":-1.631442,"eighty":5.7402,"marketCap":321200866},{"date":"2024-10-04","current":36.202393,"twenty":-9.457422,"median":-1.590554,"eighty":5.794188,"marketCap":326654191},{"date":"2024-10-11","current":41.520941,"twenty":-9.418517,"median":-1.545576,"eighty":5.81273,"marketCap":374643454},{"date":"2024-10-18","current":48.410879,"twenty":-9.361446,"median":-1.476066,"eighty":5.874322,"marketCap":436811364},{"date":"2024-10-25","current":39.738019,"twenty":-9.325428,"median":-1.427001,"eighty":5.986531,"marketCap":358556145},{"date":"2024-10-31","current":41.339627,"twenty":-9.272144,"median":-1.398379,"eighty":6.098162,"marketCap":373007457},{"date":"2024-11-08","current":42.911017,"twenty":-9.218469,"median":-1.359535,"eighty":6.156238,"marketCap":387186103},{"date":"2024-11-15","current":13.128715,"twenty":-9.046272,"median":-1.312514,"eighty":6.208115,"marketCap":339771144},{"date":"2024-11-22","current":11.461242,"twenty":-8.981394,"median":-1.249137,"eighty":6.267555,"marketCap":296616931},{"date":"2024-11-29","current":14.47958,"twenty":-8.921451,"median":-1.226648,"eighty":6.315871,"marketCap":374731519},{"date":"2024-12-06","current":13.17093,"twenty":-8.796674,"median":-1.206204,"eighty":6.377968,"marketCap":340863656},{"date":"2024-12-13","current":13.192037,"twenty":-8.54411,"median":-1.198026,"eighty":6.458123,"marketCap":341409912},{"date":"2024-12-20","current":12.01003,"twenty":-8.203383,"median":-1.189849,"eighty":6.575306,"marketCap":310819584},{"date":"2024-12-27","current":12.47439,"twenty":-8.136836,"median":-1.177582,"eighty":6.679431,"marketCap":322837213},{"date":"2025-01-03","current":12.601034,"twenty":-7.867861,"median":-1.165316,"eighty":6.722045,"marketCap":326114748},{"date":"2025-01-10","current":12.094459,"twenty":-7.746663,"median":-1.157138,"eighty":6.772383,"marketCap":313004607},{"date":"2025-01-17","current":10.680273,"twenty":-7.643946,"median":-1.144871,"eighty":6.852688,"marketCap":276405465},{"date":"2025-01-24","current":11.672314,"twenty":-7.593959,"median":-1.136694,"eighty":6.9143,"marketCap":302079490},{"date":"2025-01-31","current":11.841172,"twenty":-7.553399,"median":-1.083539,"eighty":6.984688,"marketCap":306449537},{"date":"2025-02-07","current":11.820065,"twenty":-7.487342,"median":2.995903,"eighty":7.042179,"marketCap":305903281},{"date":"2025-02-14","current":9.244979,"twenty":-7.450026,"median":3.029375,"eighty":7.078114,"marketCap":239260066},{"date":"2025-02-21","current":8.991692,"twenty":-7.412069,"median":3.058135,"eighty":7.206646,"marketCap":232704996},{"date":"2025-02-28","current":8.464011,"twenty":-7.386788,"median":3.106293,"eighty":7.356162,"marketCap":219048599},{"date":"2025-03-07","current":8.738405,"twenty":-7.341938,"median":3.158794,"eighty":7.455216,"marketCap":226149926},{"date":"2025-03-14","current":-3.452447,"twenty":-7.316986,"median":3.174613,"eighty":7.473905,"marketCap":224415987},{"date":"2025-03-21","current":-3.295325,"twenty":-7.316986,"median":3.174613,"eighty":7.473905,"marketCap":214202713},{"date":"2025-03-28","current":-3.176421,"twenty":-7.287807,"median":3.174613,"eighty":7.473905,"marketCap":206473749},{"date":"2025-04-04","current":-2.641356,"twenty":-7.25469,"median":3.174613,"eighty":7.473905,"marketCap":171693412},{"date":"2025-04-11","current":-2.539439,"twenty":-7.208699,"median":3.173175,"eighty":7.472036,"marketCap":165068586},{"date":"2025-04-17","current":-2.658342,"twenty":-7.19255,"median":3.173175,"eighty":7.472036,"marketCap":172797550},{"date":"2025-04-25","current":-2.998066,"twenty":-7.161643,"median":3.174613,"eighty":7.473905,"marketCap":194880304},{"date":"2025-05-02","current":-3.015052,"twenty":-7.117115,"median":3.174613,"eighty":7.473905,"marketCap":195984441}],"updateTime":1746262704875}}}